Le Lézard
Classified in: Health
Subject: SVY

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017



LONDON, Oct. 6, 2017 /PRNewswire/ -- Summary



Download the full report: https://www.reportbuyer.com/product/4057134


GlobalData's Medical Devices sector report, "Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
- Extensive coverage of the Colorectal Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Download the full report: https://www.reportbuyer.com/product/4057134

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com  

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com  

SOURCE ReportBuyer


These press releases may also interest you

at 13:00
Eli Lilly Canada Inc. (Lilly) is pleased to announce the Health Canada approval and availability of ENTUZITYtm KwikPen® (insulin human biosynthetic 500 units/mL) for the treatment of adults and children with diabetes requiring insulin. ENTUZITY is...

at 13:00
Vitalah®, the Proud Creators of Oxylent® (www.oxylent.com), have partnered with Whole Planet Foundation during the month of December to help alleviate poverty throughout the world. Founded in 2005, Whole Planet Foundation is a Whole Foods Market...

at 13:00
Gateway Rehab's independent correctional division Community Transitions Centers (CTC) announced that it would maintain its operations at Braddock and Erie, Pa., which were previously reported to be closing.  Following recent developments in the...

at 12:42
Midtown Wellness, is pleased to announce they now offer GAINSWavetm! This breakthrough noninvasive medical therapy uses low-intensity shockwave therapy to enhance sexual performance and to treat Erectile Dysfunction symptoms....

at 12:41
Highlighting its nationally recognized achievements in patient safety and quality, Capital Health Regional Medical Center was named a Top General Hospital by The Leapfrog Group, making it the only New Jersey hospital to earn this distinction....

at 12:41
For large hospitals and healthcare employers, specialty drugs are the single largest driver of the alarming increases in healthcare costs.  To help employers grappling with soaring costs, Strategic Benefit Advisors (SBA) has released a white paper...




News published on 6 october 2017 at 09:09 and distributed by: